Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Biomaterials ; 75: 13-24, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26474039

ABSTRACT

Many efforts have been performed in order to understand the role of recruited macrophages in the progression of spinal cord injury (SCI). Different studies revealed a pleiotropic effect played by these cells associated to distinct phenotypes (M1 and M2), showing a predictable spatial and temporal distribution in the injured site after SCI. Differently, the role of activated microglia in injury progression has been poorly investigated, mainly because of the challenges to target and selectively modulate them in situ. A delivery nanovector tool (poly-ε-caprolactone-based nanoparticles) able to selectively treat/target microglia has been developed and used here to clarify the temporal and spatial involvement of the pro-inflammatory response associated to microglial cells in SCI. We show that a treatment with nanoparticles loaded with minocycline, the latter a well-known anti-inflammatory drug, when administered acutely in a SCI mouse model is able to efficiently modulate the resident microglial cells reducing the pro-inflammatory response, maintaining a pro-regenerative milieu and ameliorating the behavioral outcome up to 63 days post injury. Furthermore, by using this selective delivery tool we demonstrate a mechanistic link between early microglia activation and M1 macrophages recruitment to the injured site via CCL2 chemokine, revealing a detrimental contribution of pro-inflammatory macrophages to injury progression after SCI.


Subject(s)
Inflammation/pathology , Microglia/pathology , Minocycline/therapeutic use , Nanoparticles/chemistry , Spinal Cord Injuries/drug therapy , Animals , Behavior, Animal/drug effects , Cell Movement/drug effects , Chemokine CCL2/metabolism , Disease Models, Animal , Disease Progression , Macrophages/drug effects , Mice, Inbred C57BL , Microglia/drug effects , Models, Biological , Nerve Regeneration/drug effects , Phenotype , Polyesters/chemistry , Spinal Cord Injuries/pathology , Spinal Cord Injuries/physiopathology
2.
Int J Antimicrob Agents ; 44(1): 47-55, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24933446

ABSTRACT

Prosthetic joint infections (PJIs) are becoming a growing public health concern in developed countries as more people undergo arthroplasty for bone fixation or joint replacement. Because a wide range of bacterial strains responsible for PJIs can produce biofilms on prosthetic implants and because the biofilm structure confers elevated bacterial resistance to antibiotic therapy, new drugs and therapies are needed to improve the clinical outcome of treatment of PJIs. Antimicrobial photodynamic therapy (APDT), a non-antibiotic broad-spectrum antimicrobial treatment, is also active against multidrug-resistant micro-organisms such as meticillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. APDT uses a photosensitiser that targets bacterial cells following exposure to visible light. APDT with RLP068/Cl, a novel photosensitiser, was studied by confocal laser scanning microscopy (CLSM) to evaluate the disruption of MRSA and P. aeruginosa biofilms on prosthetic material. Quantitative CLSM studies showed a reduction in biofilm biomass (biofilm disruption) and a decrease in viable cell numbers, as determined by standard plate counting, in the S. aureus and P. aeruginosa biofilms exposed to APDT with the photosensitiser RLP068/Cl. APDT with RLP068/Cl may be a useful approach to the treatment of PJI-associated biofilms.


Subject(s)
Anti-Bacterial Agents/pharmacology , Biofilms/drug effects , Indoles/pharmacology , Methicillin-Resistant Staphylococcus aureus/drug effects , Organometallic Compounds/pharmacology , Photosensitizing Agents/pharmacology , Pseudomonas aeruginosa/drug effects , Biofilms/growth & development , Biofilms/radiation effects , Colony Count, Microbial , Culture Media , Gentian Violet , Humans , Light , Methicillin-Resistant Staphylococcus aureus/growth & development , Methicillin-Resistant Staphylococcus aureus/radiation effects , Methicillin-Resistant Staphylococcus aureus/ultrastructure , Microbial Viability/drug effects , Microbial Viability/radiation effects , Microscopy, Confocal , Prostheses and Implants/microbiology , Pseudomonas aeruginosa/growth & development , Pseudomonas aeruginosa/radiation effects , Pseudomonas aeruginosa/ultrastructure , Titanium
SELECTION OF CITATIONS
SEARCH DETAIL
...